ARS Pharmaceuticals Inc (SPRY)
13.38
-0.17
(-1.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.21
-0.17
(-1.27%)
Pre-Market: 08:58
ARS Pharmaceuticals Total Assets (Quarterly): 217.60M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 217.60M |
| June 30, 2024 | 221.97M |
| March 31, 2024 | 227.58M |
| December 31, 2023 | 233.19M |
| September 30, 2023 | 248.56M |
| Date | Value |
|---|---|
| June 30, 2023 | 258.75M |
| March 31, 2023 | 271.19M |
| December 31, 2022 | 281.44M |
| June 30, 2022 | 46.05M |
| December 31, 2021 | 61.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
46.05M
Minimum
Jun 2022
281.44M
Maximum
Dec 2022
206.78M
Average
230.39M
Median
Total Assets (Quarterly) Benchmarks
| Exelixis Inc | 2.960B |
| Assembly Biosciences Inc | 100.26M |
| Protagonist Therapeutics Inc | 603.86M |
| Precision BioSciences Inc | 153.26M |
| Avidity Biosciences Inc | 1.641B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.62M |
| Shareholders Equity (Quarterly) | 200.98M |
| Current Ratio | 12.56 |